Alkermes price target raised to $37 from $35 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Alkermes to $37 from $35 and keeps a Neutral rating on the shares. The company reported a strong Q2 print with net sales of proprietary products reaching $269.3M, representing a 16% year-over-year increase, the analyst tells investors in a research note. The firm believes Lybalvi should be able to sustain its upward trajectory.